Your workspace
Cases
P7
PANC-07
Metastatic pancreatic adenocarcinoma
Meeting · 24 JulIn progress3 items outstanding
SO
PN
TR
EB
68% ready
M3
MEL-03
Stage III melanoma, BRAF V600E
Meeting · 18 JulReady
EB
PN
LF
Ready for meeting
C5
CHOL-05
Cholangiocarcinoma, FGFR2 fusion
Concluded · 14 JulRecommendation ready
SO
TR
Report drafted
C9
CRC-09
Colorectal, MSI-high
Meeting · 2 AugEarly prepAwaiting team & data
EB
JM
30% ready
← All cases
Overview
Meet the Team
Files & records
Discussion
Meeting
Final Report
Summaryeditable
Timeline Summary
Month 0
Diagnosis
Biopsy-confirmed PDAC, head of pancreas.
RemoveWeek 1
Tissue resection
Whipple procedure · pancreatic head tissue.
RemoveWeek 3
1st-line therapy
FOLFIRINOX started · 8 cycles planned.
RemoveMonth 5
Progression
Hepatic mets · CA 19-9 rising trend.
RemoveRemove
SO
Dr. Sana OkaforOncologist · Board leadGI & pancreatic oncology
Remove
EB
Dr. Elias BraunOncologistMelanoma & skin cancers
Remove
PN
Priya NairResearcher · BioinformaticsSingle-cell & spatial genomics
Remove
TR
Dr. Tomas ReyesResearcher · BioinformaticsTranscriptomics & pathways
P7
PANC-07PatientPancreatic adenocarcinoma · 55–60
CG
Family caregiverCaretakerSpouse · primary caregiver
AF
Dr. Ana FerreiraObserverVisiting oncology fellow
Every file is hosted externally — this is the single record of what exists for the case and who to contact for access. Add entries under any category below.
Medical records
Sequencing & multi-omics
Research reports
Therapeutic
Insight
Topic
Ranked therapeutics & insightsVote to rank · members can leave notes
7
Therapeutic
KRAS G12C inhibitor (adagrasib) — intact DDR and low TMB argue against IO-first. Consider pairing with an anti-EGFR to blunt adaptive RTK feedback.
Priya Nair: scRNA-seq supports this — RTK rebound signature is present in the resistant fraction.
4
Insight
A mesenchymal-enriched subpopulation shows FGFR1 upregulation — a plausible resistance driver worth tracking on serial ctDNA.
2
Topic
Regional KRAS G12C trial — confirm eligibility given prior FOLFIRINOX and current hepatic involvement before the board.
Personalized Multi-omics Tumor Board · Consortium
PANC-07 — Consortium meeting
An in-depth, up-to-two-hour molecular tumor board. The lead opens with a compiled overview, then the team works through each research report before recording a recommendation.
Meeting
24 July 2026
Duration
Up to 2 hours
Lead
Dr. Okafor
Format
In depth
Schedule the meeting
Members mark their availability — the lead confirms the final time.
Thursday, 24 July10:00 AM ET · up to 2 hours
Friday, 25 July2:00 PM ET · up to 2 hours
Monday, 28 July9:00 AM ET · up to 2 hours
Session outline
1
Lead overviewCompiled from all case materials
15 min
2
Report — Genomic landscapePriya Nair
15 min
3
Report — Transcriptomic profileDr. Reyes
15 min
4
Open discussionThe heart of the meeting
60 min
5
Record recommendationAgreed next steps & follow-up
15 min
Attending
SO
Dr. Sana OkaforOncologist · Lead
EB
Dr. Elias BraunOncologist
PN
Priya NairResearcher
TR
Dr. Tomas ReyesResearcher
LF
Lena FischerCoordinator
P7
PANC-07Patient · sees shared items
Final report — PANC-07
AI summary
Not yet compiled. Compile with AI to draft a summary from the case profile and discussion — or the tumor board lead can write the report below.
← Back to case
Your space
Account
Profile
Compensation
Appearance
Profile
Your identity across the workspace.
SO
Dr. Sana OkaforOncologist · Board lead · St. Martin's Oncology
Profile 80% complete — add a photo to finish.
Notifications
How Ometorium reaches you about case readiness and meetings.
Materials overdueEmail + in-app
OnMeeting reminders24h and 1h before
OnSign out
Sign out of Ometorium on this device.
Log hours by caseYour agreed rate · $850/h
| Case | Hours | Rate | Amount | |
|---|---|---|---|---|
| PANC-07 | $850/h | $3,400 | ||
| MEL-03 | $850/h | $1,700 | ||
| CHOL-05 | $850/h | $3,400 |
Total
$8,500
Project engagements+ New proposal
PANC-07 — integrated multi-omics analysis
$7,500
Scope_proposal_PANC-07.pdfIn progress
CRC-09 — WES + RNA-seq
$6,000
Upload scope proposalProposed
Project work is billed against an agreed, uploaded scope — tracked separately from hourly time. Spatial & single-cell integration is scoped per project.
Direct deposit
Paid straight to your US bank account by ACH.
Bank details are collected securely.
Appearance
Ometorium follows your device's light or dark setting by default. Override it here just for your account.
Following your device setting.
← Account
Your account
Edit profile
Profile photoRequired
● Photo not added — you're using a default avatar
SO
Add a real photo of yourself
A clear headshot helps the consortium recognize you in meetings and on the recommendations you sign. Required to complete your profile.
Identity & credentials
Clinical focus & expertise
Biomarker experience
Therapeutic areas
Diagnostics
Short bio
Training & appointments
Current appointments
None yet. Add manually.
Publications—
No publications yet. Add them manually.
Profile completeness
80%
CredentialsVerified
Expertise10 tags
ContactDone
Short bioDone
!Profile photoMissing
Your workspace
My Tasks
2
Overdue
5
Due this week
12
Completed this month
Assigned by you+ Assign task
Complete transcriptomic analysis — PANC-07Assigned to Dr. Reyes · due 22 Jul
AwaitingConfirm case review complete — CHOL-05Assigned to Dr. Okafor · due 18 Jul
ConfirmedConfirm attendance — MEL-03 meetingAssigned to Dr. Braun · 18 Jul
AwaitingNeeds attention
Add RNA-seq raw (PANC-07)Required file · blocking the meeting
Overdue · 20 JulAdd your profile photoProfile 80% complete
OverdueDue this week
Confirm attendance — PANC-07 meeting24 Jul · up to 2 hours
Due todayReview research report — CHOL-05Genomic landscape · Priya Nair
WedRespond to invitation — CRC-09Invited by Dr. Braun
2 AugCase intake
Submit a case
Bring a case to a Personalized Multi-omics Tumor Board. Add the basics now. The team and files come together on the case page afterward.
1Case
2Diagnosis
3Brief summary
Urgency
RoutinePriorityUrgent
Meeting level
$15k
Basic
1 researcher, 2 oncologists
Most common
$65k
Comprehensive
2 researchers, up to 6 oncologists
Custom
Advanced
Custom, expanded multi-omics
Billing
Please confirm the billing acknowledgement to submit.
Researcher · Bioinformatics
Worklist
Your action items, data uploads, and research reports across active cases.
1
Overdue
3
Due this week
8
Delivered this month
Needs attention
Respond to invitation — CRC-09Invited by Dr. Braun
2 AugConfirm attendance — PANC-07 meeting24 Jul · up to 2 hours
Due todayData to deliver
| Case | Data | Due | Status | |
|---|---|---|---|---|
| PANC-07 | RNA-seq raw (FASTQ) | Overdue · 20 Jul | Missing | |
| PANC-07 | WES raw (FASTQ) | 21 Jul | Verified | |
| CRC-09 | WES raw (FASTQ) | 30 Jul | Not started |
Reports to submit
| Case | Report | Due | Status | |
|---|---|---|---|---|
| PANC-07 | Transcriptomic profile & pathways | 22 Jul | In draft | |
| CRC-09 | Genomic landscape | 31 Jul | Not started |
Administration
Admin console
Members & roles
All members
PANC-07
MEL-03
CHOL-05
CRC-09
| Member | Role | Institution | Pay rate | Status |
|---|
Pay rates are set here at onboarding, based on each member's agreement — hourly for oncologists, hourly or per-project for researchers.
Invitations
| Invitee | Role | Case | Sent | Status | |
|---|---|---|---|---|---|
| Dr. Elias Braun | Oncologist | PANC-07 | 3d ago | Pending | |
| Dr. Wei Chen | Researcher | CRC-09 | 1d ago | Accepted | |
| Dr. Julia Meyer | Oncologist | PANC-07 | 4d ago | Declined |
Templates · required files per case type
Solid tumor (default)This defines the minimum-required files a case must have before it can reach “Ready.”
WESRaw FASTQ · Researcher
RequiredWGSRaw FASTQ · Researcher
OptionalRNA sequencingRaw FASTQ · Researcher
RequiredProteomicsResearcher
OptionalMedical record / Treatment historyOncologist
RequiredPathology reportsOncologist
RequiredLab testsOncologist
RequiredQuorum rules
A case cannot reach “Ready” until quorum is met.
Meeting format
Session outline: Lead overview 15m · reports 15m each · open discussion 60m · recommendation 15m.
Case teams
Add or remove members from a case. The workspace stays read-only — team changes are managed here.
SO
Dr. Sana OkaforOncologist · Board lead
LeadEB
Dr. Elias BraunOncologist
PN
Priya NairResearcher
TR
Dr. Tomas ReyesResearcher
LF
Lena FischerCoordinator
Administration
Operations
6.4 days
Median time to ready
3
Overdue materials
5
Meetings this month
4%
No-show rate
Cases boarded per month
Readiness by case
PANC-07Meeting 24 Jul
MEL-03Meeting 18 Jul
CRC-09Meeting 2 Aug
Turnaround detail
| Case | Opened | Meeting | Time to ready | Overdue items | Status |
|---|---|---|---|---|---|
| PANC-07 | 06 Jul | 24 Jul | — | 1 | In progress |
| MEL-03 | 02 Jul | 18 Jul | 5.1 days | 0 | Ready |
| CHOL-05 | 28 Jun | 14 Jul | 6.4 days | 0 | Concluded |
| CRC-09 | 10 Jul | 02 Aug | — | 2 | Early prep |
Administration
Audit & compliance log
All eventsAccessUploadsDecisionsAdmin
| Timestamp | Actor | Action | Target | Case |
|---|---|---|---|---|
| 2026-07-15 09:42 | P. Nair | Uploaded file | WES_tumor-normal.fastq.gz | PANC-07 |
| 2026-07-15 09:40 | S. Okafor | Reviewed report | Nair_genomic-report.pdf | PANC-07 |
| 2026-07-14 16:20 | S. Okafor | Recorded recommendation | #MTB-0138 | CHOL-05 |
| 2026-07-14 16:18 | T. Reyes | Recorded dissent | #MTB-0138 | CHOL-05 |
| 2026-07-14 11:05 | L. Fischer | Promoted to patient-visible | Recommendation | CHOL-05 |
| 2026-07-13 14:31 | S. Okafor | Accessed medical record | Pathology_report.pdf | PANC-07 |
| 2026-07-12 10:02 | L. Fischer | Sent invitation | Dr. E. Braun · Oncologist | PANC-07 |
| 2026-07-11 08:47 | L. Fischer | Changed role | W. Chen → Researcher | — |
Immutable, append-only record — retained for defensibility and accreditation. Exportable as a signed report.
Your tumor board is being preparedMeeting 24 Jul
06 Jul
Case opened
Done
08 Jul
Your board
Assembled
now
Records & analysis
In progress
by 22 Jul
Expert review
Upcoming
Meeting
24 Jul
You're invited
What happens next
A team of oncologists and research scientists is preparing your case — gathering your records and running advanced multi-omics analyses of your tumor. On 24 July they meet as a board to review everything together and agree on recommendations for your care. You're invited to join the meeting by video, and your care lead will walk you through the outcome afterward. This advanced analysis is carried out as part of an IRB-approved research study you've consented to.
My task list3 to do
What your board needs from you to prepare your case.
Add records from your previous oncologistMedical records
Due 21 JulAdd outside tumor sequencing, if you have itSequencing files (WES / RNA-seq) · optional
OptionalConfirm you'll attend the meeting24 Jul · by video
This weekReview the summary shared with youFrom Dr. Okafor
DoneYour personalized molecular tumor board
SO
Dr. Sana OkaforOncologist · Board lead
EB
Dr. Elias BraunOncologist
PN
Priya NairResearch scientist
TR
Dr. Tomas ReyesResearch scientist
LF
Lena FischerCare coordinator
Your meeting
24 July 2026
You're invited to attend by video · up to 2 hours
Administration
Payouts
$12,400
Pending payout
$18,300
Paid this month
3
Open project engagements
| Member | Type | For | Amount | Method | Status | |
|---|---|---|---|---|---|---|
| SODr. Sana Okafor | Hourly | PANC-07 · 4h | $3,400 | Direct deposit | Submitted | |
| SODr. Sana Okafor | Hourly | MEL-03 · 2h | $1,700 | Direct deposit | Draft | |
| PNPriya Nair | Project | PANC-07 multi-omics | $7,500 | Direct deposit | In progress | |
| TRDr. Tomas Reyes | Project | CRC-09 WES + RNA-seq | $6,000 | — | Proposed | |
| EBDr. Elias Braun | Hourly | NSCLC-11 · 4h | $3,400 | Direct deposit | Paid 15 Jul |
Approve submitted invoices to release payment. Project engagements pay against their agreed, uploaded scope.
Administration
Case economics
Projected cost is built from the engaged oncologists' and researchers' real rates. Real cost lands as each group submits their hours. Case value is what the patient is billed for the chosen offering.